Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Prepaid Assets: 2016-2024

Historic Prepaid Assets for Tg Therapeutics (TGTX) over the last 9 years, with Dec 2024 value amounting to $15.7 million.

  • Tg Therapeutics' Prepaid Assets rose 71.14% to $55.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.8 million, marking a year-over-year increase of 71.14%. This contributed to the annual value of $15.7 million for FY2024, which is 65.10% up from last year.
  • As of FY2024, Tg Therapeutics' Prepaid Assets stood at $15.7 million, which was up 65.10% from $9.5 million recorded in FY2023.
  • In the past 5 years, Tg Therapeutics' Prepaid Assets ranged from a high of $15.7 million in FY2024 and a low of $4.2 million during FY2022.
  • Over the past 3 years, Tg Therapeutics' median Prepaid Assets value was $9.5 million (recorded in 2023), while the average stood at $9.8 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first spiked by 128.04% in 2021, then tumbled by 64.48% in 2022.
  • Yearly analysis of 5 years shows Tg Therapeutics' Prepaid Assets stood at $5.2 million in 2020, then skyrocketed by 128.04% to $11.9 million in 2021, then tumbled by 64.48% to $4.2 million in 2022, then soared by 124.66% to $9.5 million in 2023, then soared by 65.10% to $15.7 million in 2024.